NURTURING WELLNESS: UNVEILING THE THERAPEUTIC POTENTIAL OF LACTIC ACID BACTERIA IN THE MANAGEMENT OF HELICOBACTER PYLORI-INDUCED GASTRITIS

Abstract

This study delves into the therapeutic landscape of managing Helicobacter pylori-induced gastritis by exploring the potential of lactic acid bacteria (LAB) as probiotics. Helicobacter pylori infection remains a global health concern, contributing to gastritis and peptic ulcer disease. The aim of this research is to unveil the mechanisms through which LAB exert their probiotic effects in mitigating H. pylori-induced inflammation. Through a comprehensive review of current literature, clinical studies, and experimental findings, we aim to shed light on the promising role of LAB in promoting gastrointestinal health and addressing the challenges posed by H. pylori gastritis.

Keywords:

Lactic Acid Bacteria (LAB), Helicobacter pylori, gastritis, probiotics, gastrointestinal health, therapeutic potential, inflammation, peptic ulcer disease, microbial balance, bacterial interference

References

Tumonggor MK, Karafet TM, Hallmark B, Lansing JS, Sudoyo H, Hammer MF, et al. (2015) The Indonesian archipelago: an ancient genetic highway linking Asia and the Pacific. J Hum Genet. 58(3):165–73.

Sipponen P, Maaroos H-I (2015) Chronic gastritis. Scand J Gastroenterol 50(6):657–67.

Kementrian Kesehatan Republik Indonesia (2011) Profil Kesehatan Indonesia 2011. Jakarta: Kementrian Kesehatan RI.

Peek RM, Blaser MJ (2002) Helicobacter pylori and gastroin-testinal tract adenocarcinomas. Nat Rev Cancer 2(1):28–37.

Mhaskar RS, Ricardo I, Azliyati A, Laxminarayan R, Amol B, Santosh W, et al (2013) Assessment of risk factors of helico-bacter pylori infection and peptic ulcer disease. J Glob Infect Dis 5(2):60–7.

Behnsen J, Deriu E, Sassone-Corsi M, Raffatellu M (2013) Pro-biotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med. 3(3): a010074.

Patel A, Shah N, Prajapati JB (2014) Clinical application of probiotics in the treatment of Helicobacter pylori infection--a brief review. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi 47(5):429–37.

Gisbert JP, McNicholl AG (2017) Optimization strategies aimed to increase the efficacy of H. Pylori eradication thera-pies. Helicobacter 22(4): 1-9.

Solnick JV, Schauer DB (2001) Emergence of Diverse Helico-bacter Species in the Pathogenesis of Gastric and Enterohe-patic Diseases. Clin Microbiol Rev. 14(1):59–97.

Homan M, Orel R (2015) Are probiotics useful in Helicobac-ter pylori eradication? World J Gastroenterol WJG. 21(37):10644–53.

Homan M, Šterbenc A, Kocjan BJ, Luzar B, Zidar N, Orel R, et al. (2014) Prevalence of the Helicobacter pylori babA2 gene and correlation with the degree of gastritis in infected Slove-nian children. Antonie Van Leeuwenhoek 106(4):637–45.

Kodama M, Murakami K, Okimoto T, Abe T, Nakagawa Y, Mi-zukami K, et al. (2012) Helicobacter pylorieradication improves gastric atrophy and intestinal metaplasia in long-term observation. Digestion 85(2):126–30.